Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets (Unaudited)

v3.24.3
Condensed Consolidated Balance Sheets (Unaudited) - USD ($)
$ in Thousands
Sep. 30, 2024
Dec. 31, 2023
Current assets    
Cash and cash equivalents $ 23,537 $ 14,907
Restricted cash 1,114 957
Other current assets 3,665 1,768
Total current assets 28,316 17,632
Non-current assets    
Other assets 96
Operating lease right-of-use assets 9,700 3,495
Property and equipment, net 6,581 3,902
In-process Research and development (“IPR&D”) assets 15,287
Total non-current assets 31,664 7,397
Total Assets 59,980 25,029
Current liabilities    
Trade accounts payable 2,779 1,381
Current portion of lease liabilities 1,096 666
Other accounts payable 5,069 3,344
Current portion of long-term debt 5,785
Total current liabilities 8,944 11,176
Non-current liabilities    
Contract liability 1,976
Long-term debt, net of current portion 5,402
Operating lease liabilities, net of current portion 8,651 3,239
Other liabilities 161 155
Private Placement Warrants 4,328
Total non-current liabilities 13,140 10,772
Commitments and Contingencies (Note 7)
Stockholders’ equity    
Preferred Stock, $0.0001 par value; Authorized – 1,000,000 shares as of September 30, 2024 and December 31, 2023. Issued and outstanding- 147,735 as of September 30, 2024. No shares issued and outstanding as of December 31, 2023. 18,645
Common Stock, $0.0001 par value; Authorized – 750,000,000 shares as of September 30, 2024 and 120,000,000 shares as of December 31, 2023. Issued and outstanding- 18,176,602 shares as of September 30, 2024 and 4,723,320 shares as of December 31, 2023. [1] 6 3
Additional paid in capital 185,429 166,048
Accumulated deficit (166,184) (162,970)
Total stockholders’ equity 37,896 3,081
Total liabilities and stockholders’ equity $ 59,980 $ 25,029
[1] All share amounts have been retroactively adjusted to reflect a 1-for-10 reverse share split as discussed in Note 10A.